371 related articles for article (PubMed ID: 26711696)
21. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Farrukh L; Steen VD; Shapiro L; Mehta S
Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
[TBL] [Abstract][Full Text] [Related]
22. Therapy of scleroderma renal crisis: State of the art.
Zanatta E; Polito P; Favaro M; Larosa M; Marson P; Cozzi F; Doria A
Autoimmun Rev; 2018 Sep; 17(9):882-889. PubMed ID: 30005860
[TBL] [Abstract][Full Text] [Related]
23. A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.
Akoglu H; Atilgan GK; Ozturk R; Yenigun EC; Gonul II; Odabas AR
Rheumatol Int; 2009 Aug; 29(10):1223-9. PubMed ID: 19048256
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis, management and prevention of scleroderma renal disease.
Penn H; Denton CP
Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
[TBL] [Abstract][Full Text] [Related]
25. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
Hosing C; Nash R; McSweeney P; Mineishi S; Seibold J; Griffith LM; Shulman H; Goldmuntz E; Mayes M; Parikh CR; Crofford L; Keyes-Elstein L; Furst D; Steen V; Sullivan KM
Biol Blood Marrow Transplant; 2011 May; 17(5):674-81. PubMed ID: 20708086
[TBL] [Abstract][Full Text] [Related]
26. Kidney crisis in systemic sclerosis.
Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690
[TBL] [Abstract][Full Text] [Related]
27. Scleroderma renal crisis.
Steen VD
Rheum Dis Clin North Am; 2003 May; 29(2):315-33. PubMed ID: 12841297
[TBL] [Abstract][Full Text] [Related]
28. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
Shimizu T; Iwamoto N; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Umeda M; Fukui S; Sumiyoshi R; Kitamura M; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
Intern Med; 2019 Feb; 58(3):441-445. PubMed ID: 30146597
[TBL] [Abstract][Full Text] [Related]
29. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases.
Traub YM; Shapiro AP; Rodnan GP; Medsger TA; McDonald RH; Steen VD; Osial TA; Tolchin SF
Medicine (Baltimore); 1983 Nov; 62(6):335-52. PubMed ID: 6355755
[TBL] [Abstract][Full Text] [Related]
30. [Renal involvement in patients with systemic sclerosis].
Bussone G; Noël LH; Mouthon L
Nephrol Ther; 2011 Jun; 7(3):192-9. PubMed ID: 21524952
[TBL] [Abstract][Full Text] [Related]
31. Scleroderma renal crisis in tropical region: two senegalese cases.
Cisse MM; Seck SM; Oumar DA; Fall K; Lemrabott AT; Diallo M; Faye M; Faye M; Niang A; Diouf B
Pan Afr Med J; 2015; 21():46. PubMed ID: 26405482
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
[TBL] [Abstract][Full Text] [Related]
33. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
[TBL] [Abstract][Full Text] [Related]
34. De novo normotensive scleroderma renal crisis six years after living-donor renal transplantation in a patient with overlapping systemic sclerosis/systemic lupus erythematosus syndrome: a case report.
Sanada H; Hara S; Horita M; Kawahara H; Yoshida M; Takahashi Y; Tsuge S; Zoshima T; Nishioka R; Ito K; Mizushima I; Matsushita T; Kawano M
BMC Nephrol; 2023 Dec; 24(1):355. PubMed ID: 38049714
[TBL] [Abstract][Full Text] [Related]
35. Renal complications and scleroderma renal crisis.
Denton CP; Lapadula G; Mouthon L; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii32-5. PubMed ID: 19487221
[TBL] [Abstract][Full Text] [Related]
36. UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.
Lynch BM; Stern EP; Ong V; Harber M; Burns A; Denton CP
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):106-109. PubMed ID: 27749244
[TBL] [Abstract][Full Text] [Related]
37. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
[TBL] [Abstract][Full Text] [Related]
38. Scleroderma Renal Crisis.
Guillevin L; Mouthon L
Rheum Dis Clin North Am; 2015 Aug; 41(3):475-88. PubMed ID: 26210130
[TBL] [Abstract][Full Text] [Related]
39. Favourable outcome of scleroderma renal crisis.
Collins DA; Patel S; Eastwood JB; Bourke BE
J R Soc Med; 1996 Jan; 89(1):49P-50P. PubMed ID: 8709086
[TBL] [Abstract][Full Text] [Related]
40. Kidney involvement in systemic sclerosis.
Steen VD
Presse Med; 2014 Oct; 43(10 Pt 2):e305-14. PubMed ID: 25174767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
